|
Volumn 24, Issue 5, 1992, Pages 637-646
|
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: A prospective, randomized and controlled study of efficacy and safety
a b c d e f g h e i a j
d
Sarpsborg Hospital
*
(Norway)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
CEFUROXIME;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TOBRAMYCIN;
URINARY TRACT ANTIINFECTIVE AGENT;
ADULT;
AGED;
ANAEROBIC BACTERIUM;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
DIARRHEA;
DRUG EFFICACY;
DRUG FEVER;
DRUG SAFETY;
FATIGUE;
FEMALE;
HEARING IMPAIRMENT;
HUMAN;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY DISEASE;
LOWER RESPIRATORY TRACT INFECTION;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC DISORDER;
MINIMUM INHIBITORY CONCENTRATION;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PHLEBITIS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROTEINURIA;
RASH;
SEPTICEMIA;
STREPTOCOCCUS PNEUMONIAE;
URINARY TRACT INFECTION;
ADULT;
AGED;
ANTIBIOTICS, COMBINED;
BACTEREMIA;
CEFUROXIME;
CIPROFLOXACIN;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
MALE;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGE;
PROSPECTIVE STUDIES;
RESPIRATORY TRACT INFECTIONS;
SUPPORT, NON-U.S. GOV'T;
TOBRAMYCIN;
TREATMENT OUTCOME;
URINARY TRACT INFECTIONS;
|
EID: 0026462886
PISSN: 00365548
EISSN: None
Source Type: Journal
DOI: 10.3109/00365549209054651 Document Type: Article |
Times cited : (20)
|
References (18)
|